Teva to Develop Unique Wearable Tech and Machine Learning Platform for Continuous Measurement and Analysis of Huntington Disease Symptoms in Collaboration with Intel

News This platform will continuously monitor and analyze key symptoms that impact daily living, in an effort to better understand disease progression and improve treatment evaluation. Contributed Author:  Teva Pharmaceutical Industries Ltd. Topics:  Wearables